Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Rapid growth is a dominant predictor of hepcidin suppression and declining ferritin in Gambian infants.

Armitage AE, Agbla SC, Betts M, Sise EA, Jallow MW, Sambou E, Darboe B, Worwui A, Weinstock GM, Antonio M, Pasricha SR, Prentice AM, Drakesmith H, Darboe MK, Kwambana-Adams BA.

Haematologica. 2019 Feb 7. pii: haematol.2018.210146. doi: 10.3324/haematol.2018.210146. [Epub ahead of print]

2.

More than 18,000 effectors in the Legionella genus genome provide multiple, independent combinations for replication in human cells.

Gomez-Valero L, Rusniok C, Carson D, Mondino S, Pérez-Cobas AE, Rolando M, Pasricha S, Reuter S, Demirtas J, Crumbach J, Descorps-Declere S, Hartland EL, Jarraud S, Dougan G, Schroeder GN, Frankel G, Buchrieser C.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2265-2273. doi: 10.1073/pnas.1808016116. Epub 2019 Jan 18.

PMID:
30659146
3.

Fortification of maize flour with iron for controlling anaemia and iron deficiency in populations.

Garcia-Casal MN, Peña-Rosas JP, De-Regil LM, Gwirtz JA, Pasricha SR.

Cochrane Database Syst Rev. 2018 Dec 22;12:CD010187. doi: 10.1002/14651858.CD010187.pub2. Review.

PMID:
30577080
4.

Are Current Serum and Plasma Ferritin Cut-offs for Iron Deficiency and Overload Accurate and Reflecting Iron Status? A Systematic Review.

Garcia-Casal MN, Pasricha SR, Martinez RX, Lopez-Perez L, Peña-Rosas JP.

Arch Med Res. 2018 Aug;49(6):405-417. doi: 10.1016/j.arcmed.2018.12.005. Epub 2018 Dec 17. Review.

PMID:
30573199
5.

Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature.

Tandon S, Gairola M, Ahlawat P, Sharma K, Barik S, Sachdeva N, Pasricha S, Shenoy A.

Radiat Oncol J. 2018 Dec;36(4):341-347. doi: 10.3857/roj.2018.00304. Epub 2018 Dec 7.

6.

Hemoglobinopathies in the Fetal Position.

Pasricha SR, Drakesmith H.

N Engl J Med. 2018 Oct 25;379(17):1675-1677. doi: 10.1056/NEJMcibr1809628. No abstract available.

PMID:
30354961
7.

Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice.

Artuso I, Pettinato M, Nai A, Pagani A, Sardo U, Billoré B, Lidonnici MR, Bennett C, Mandelli G, Pasricha SR, Ferrari G, Camaschella C, Kautz L, Silvestri L.

Haematologica. 2019 Mar;104(3):e87-e90. doi: 10.3324/haematol.2018.199810. Epub 2018 Sep 28. No abstract available.

8.

Treatment conundrums in osteosarcoma of the breast: Two clinical cases from a tertiary care cancer center in India.

Doval DC, Tayal J, Choudhary KD, Goyal P, Gupta G, Pasricha S.

Turk J Surg. 2018 Sep 13:1-4. doi: 10.5152/turkjsurg.2018.4075. [Epub ahead of print]

PMID:
30248287
9.

Nasopharyngeal carcinoma with unusual metastasis to urinary bladder.

Seth N, Gandhi JS, Pasricha S, Mehta A.

J Cancer Res Ther. 2018 Jul-Sep;14(5):1160-1161. doi: 10.4103/0973-1482.204844.

10.

Erythroferrone inhibits the induction of hepcidin by BMP6.

Arezes J, Foy N, McHugh K, Sawant A, Quinkert D, Terraube V, Brinth A, Tam M, LaVallie ER, Taylor S, Armitage AE, Pasricha SR, Cunningham O, Lambert M, Draper SJ, Jasuja R, Drakesmith H.

Blood. 2018 Oct 4;132(14):1473-1477. doi: 10.1182/blood-2018-06-857995. Epub 2018 Aug 10.

11.

Reducing anaemia in low income countries: control of infection is essential.

Pasricha SR, Armitage AE, Prentice AM, Drakesmith H.

BMJ. 2018 Aug 1;362:k3165. doi: 10.1136/bmj.k3165. No abstract available.

12.

Decreased Hepcidin Levels Are Associated with Low Steady-state Hemoglobin in Children With Sickle Cell Disease in Tanzania.

Lee N, Makani J, Tluway F, Makubi A, Armitage AE, Pasricha SR, Drakesmith H, Prentice AM, Cox SE.

EBioMedicine. 2018 Aug;34:158-164. doi: 10.1016/j.ebiom.2018.07.024. Epub 2018 Jul 25.

13.

Breast Cancer Recurrence Presenting as Solitary Intraparotid Nodal Metastasis Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography: A Very Unusual Occurrence.

Agrawal CR, Dutta K, Doval DC, Pasricha S, Gupta M.

Indian J Nucl Med. 2018 Jul-Sep;33(3):233-236. doi: 10.4103/ijnm.IJNM_17_18.

14.

Bizarre multilobated myeloma cells mimicking megakaryocytes.

Pasricha S, Singh N, Panaych A, Mehta A.

Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):248-250. doi: 10.1016/j.hemonc.2018.04.003. Epub 2018 May 19. No abstract available.

15.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.

Pasricha SV, Tadrous M, Khuu W, Juurlink DN, Mamdani MM, Paterson JM, Gomes T.

Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.

16.

Targeting of RNA Polymerase II by a nuclear Legionella pneumophila Dot/Icm effector SnpL.

Schuelein R, Spencer H, Dagley LF, Li PF, Luo L, Stow JL, Abraham G, Naderer T, Gomez-Valero L, Buchrieser C, Sugimoto C, Yamagishi J, Webb AI, Pasricha S, Hartland EL.

Cell Microbiol. 2018 Sep;20(9):e12852. doi: 10.1111/cmi.12852. Epub 2018 May 18.

PMID:
29691989
17.

Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients.

Srivastava H, Dewan A, Sharma SK, Negi P, Dewan AK, Pasricha S, Mehrotra K.

Asian J Neurosurg. 2018 Apr-Jun;13(2):297-301. doi: 10.4103/ajns.AJNS_151_16.

18.

Primary squamous cell carcinoma of the ampulla.

Sekhri R, Kamboj M, Gupta G, Pasricha S.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):300-302. doi: 10.4103/IJPM.IJPM_340_17. No abstract available.

19.

Urothelial carcinoma of urinary bladder with exclusive heterologous component of epithelioid rhabdomyosarcoma at metastatic site.

Agarwal P, Pasricha S, Gupta G, Sharma A, Mehta A.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):258-260. doi: 10.4103/IJPM.IJPM_785_17.

20.

Talaromyces marneffei simA Encodes a Fungal Cytochrome P450 Essential for Survival in Macrophages.

Boyce KJ, De Souza DP, Dayalan S, Pasricha S, Tull D, McConville MJ, Andrianopoulos A.

mSphere. 2018 Mar 21;3(2). pii: e00056-18. doi: 10.1128/mSphere.00056-18. eCollection 2018 Mar-Apr.

21.

Heterogeneous hemoglobin lower thresholds in clinical laboratories.

Colman KS, Wood EM, De La Salle B, Stanworth SJ, Pasricha SR.

Am J Hematol. 2018 Jun;93(6):E142-E144. doi: 10.1002/ajh.25080. Epub 2018 Mar 30. No abstract available.

PMID:
29498082
22.

Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health.

Pasricha SR, Colman K, Centeno-Tablante E, Garcia-Casal MN, Peña-Rosas JP.

Lancet Haematol. 2018 Feb;5(2):e60-e62. doi: 10.1016/S2352-3026(18)30004-8. No abstract available.

PMID:
29406148
23.

Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?

Singh N, Pasricha S, Agrawal N, Gandhi JS, Panaych A, Mehta A, Ahmed R, Bhurani D.

Indian J Hematol Blood Transfus. 2018 Jan;34(1):194-196. doi: 10.1007/s12288-017-0839-3. Epub 2017 Jun 15. No abstract available.

24.

Florid Plasmacytosis in Angioimmunoblastic T Cell Lymphoma: A Diagnostic Conundrum.

Singh N, Sharma A, Pasricha S, Agrawal N, Bhurani D, Gupta G, Mehta A.

Indian J Hematol Blood Transfus. 2018 Jan;34(1):188-190. doi: 10.1007/s12288-017-0824-x. Epub 2017 May 19. No abstract available.

25.

Iron and Cognitive Development: What Is the Evidence?

Larson LM, Phiri KS, Pasricha SR.

Ann Nutr Metab. 2017;71 Suppl 3:25-38. doi: 10.1159/000480742. Epub 2017 Dec 22.

26.

Impact of 2013 ASCO/CAP HER2 reporting guidelines in breast cancer: An assessment study from Indian oncology centre that primarily performs HER2 IHC testing with special emphasis on IHC equivocal category.

Pasricha S, Gupta G, Garg R, Sharma A, Gandhi JS, Durga G, Kamboj M, Grover S, Mehta A.

Breast J. 2018 Jul;24(4):468-472. doi: 10.1111/tbj.12981. Epub 2017 Dec 18.

PMID:
29251392
27.

Isolated myeloid sarcoma of cervix: Aleukemic presentation.

Kamboj M, Sharma A, Gupta G, Pasricha S.

J Cancer Res Ther. 2017 Oct-Dec;13(6):1076-1077. doi: 10.4103/0973-1482.176418. No abstract available.

28.

A study of the pathological outcome of positron emission tomography-computed tomography 2-(18F)-fluro-2-deoxy-D-glucose avid lesion: A 5 years retrospective study.

Gupta G, Gandhi JS, Sharma A, Pasricha S, Mehta A, Rao A, Kamboj M.

J Cancer Res Ther. 2017 Oct-Dec;13(6):1000-1006. doi: 10.4103/0973-1482.165874.

29.

Benefits and risks of Iron interventions in children (BRISC): protocol for a three-arm parallel-group randomised controlled field trial in Bangladesh.

Hasan MI, Hossain SJ, Braat S, Dibley MJ, Fisher J, Grantham-McGregor S, Tofail F, Simpson JA, Arifeen SE, Hamadani J, Biggs BA, Pasricha SR.

BMJ Open. 2017 Nov 15;7(11):e018325. doi: 10.1136/bmjopen-2017-018325.

30.

Assessment of iron status in settings of inflammation: challenges and potential approaches.

Suchdev PS, Williams AM, Mei Z, Flores-Ayala R, Pasricha SR, Rogers LM, Namaste SM.

Am J Clin Nutr. 2017 Dec;106(Suppl 6):1626S-1633S. doi: 10.3945/ajcn.117.155937. Epub 2017 Oct 25. Review.

31.

Serum ferritin as an indicator of iron status: what do we need to know?

Daru J, Colman K, Stanworth SJ, De La Salle B, Wood EM, Pasricha SR.

Am J Clin Nutr. 2017 Dec;106(Suppl 6):1634S-1639S. doi: 10.3945/ajcn.117.155960. Epub 2017 Oct 25. Review.

32.

Study of association of Epstein-Barr virus in lymphomas by Epstein-Barr virus-encoded RNA in situ hybridization: An Indian perspective from a tertiary care cancer institute.

Gala R, Gandhi JS, Gupta G, Grover SK, Sharma A, Pasricha S, Mehta A.

Indian J Pathol Microbiol. 2017 Jul-Sep;60(3):341-349. doi: 10.4103/IJPM.IJPM_49_17.

33.

Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia major.

Wong P, Milat F, Fuller PJ, Kerr PG, Doery JCG, Oh DH, Jackson D, Gillespie MT, Bowden DK, Pasricha SR, Lau KK.

Intern Med J. 2017 Sep;47(9):1064-1067. doi: 10.1111/imj.13533.

PMID:
28891172
34.

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.

Pasricha SR, Lim PJ, Duarte TL, Casu C, Oosterhuis D, Mleczko-Sanecka K, Suciu M, Da Silva AR, Al-Hourani K, Arezes J, McHugh K, Gooding S, Frost JN, Wray K, Santos A, Porto G, Repapi E, Gray N, Draper SJ, Ashley N, Soilleux E, Olinga P, Muckenthaler MU, Hughes JR, Rivella S, Milne TA, Armitage AE, Drakesmith H.

Nat Commun. 2017 Sep 1;8(1):403. doi: 10.1038/s41467-017-00500-z.

35.

Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen Talaromyces marneffei.

Pasricha S, MacRae JI, Chua HH, Chambers J, Boyce KJ, McConville MJ, Andrianopoulos A.

Front Cell Infect Microbiol. 2017 Aug 17;7:368. doi: 10.3389/fcimb.2017.00368. eCollection 2017.

36.

Should Benzodiazepines and Anticonvulsants Be Used During Electroconvulsive Therapy?: A Case Study and Literature Review.

Tang VM, Pasricha AN, Blumberger DM, Voineskos D, Pasricha S, Mulsant BH, Daskalakis ZJ.

J ECT. 2017 Dec;33(4):237-242. doi: 10.1097/YCT.0000000000000441. Review.

PMID:
28767528
37.

Hepatic iron is the major determinant of serum ferritin in NAFLD patients.

Ryan JD, Armitage AE, Cobbold JF, Banerjee R, Borsani O, Dongiovanni P, Neubauer S, Morovat R, Wang LM, Pasricha SR, Fargion S, Collier J, Barnes E, Drakesmith H, Valenti L, Pavlides M.

Liver Int. 2018 Jan;38(1):164-173. doi: 10.1111/liv.13513. Epub 2017 Jul 29.

PMID:
28679028
38.

Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas.

Gandhi JS, Goswami M, Sharma A, Tanwar P, Gupta G, Gupta N, Pasricha S, Mehta A, Singh S, Agarwal M, Gupta N.

J Gastrointest Cancer. 2018 Dec;49(4):406-414. doi: 10.1007/s12029-017-9954-5.

PMID:
28585041
39.

Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.

Cotton CC, Wolf WA, Overholt BF, Li N, Lightdale CJ, Wolfsen HC, Pasricha S, Wang KK, Shaheen NJ; AIM Dysplasia Trial Group.

Gastroenterology. 2017 Sep;153(3):681-688.e2. doi: 10.1053/j.gastro.2017.05.044. Epub 2017 Jun 1.

40.

Postdonation iron replacement for maintaining iron stores in female whole blood donors in routine donor practice: results of two feasibility studies in Australia.

Pasricha SR, Marks DC, Salvin H, Brama T, Keller AJ, Pink J, Speedy J.

Transfusion. 2017 Aug;57(8):1922-1929. doi: 10.1111/trf.14173. Epub 2017 May 18.

PMID:
28518220
41.

Luminescence, circular dichroism and in silico studies of binding interaction of synthesized naphthylchalcone derivatives with bovine serum albumin.

Pasricha S, Sharma D, Ojha H, Gahlot P, Pathak M, Basu M, Chawla R, Singhal S, Singh A, Goel R, Kukreti S, Shukla S.

Luminescence. 2017 Nov;32(7):1252-1262. doi: 10.1002/bio.3319. Epub 2017 May 16.

PMID:
28512990
42.

Clinicopathological Characteristics and Prognostic Factors of Synchronous Endometrial and Ovarian Cancers-A Single-Institute Review of 43 Cases.

Jain V, Sekhon R, Pasricha S, Giri S, Modi KB, Shrestha E, Ram D, Rawal S.

Int J Gynecol Cancer. 2017 Jun;27(5):938-946. doi: 10.1097/IGC.0000000000000971.

PMID:
28498249
43.

Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia.

Bah A, Pasricha SR, Jallow MW, Sise EA, Wegmuller R, Armitage AE, Drakesmith H, Moore SE, Prentice AM.

J Nutr. 2017 Jun;147(6):1131-1137. doi: 10.3945/jn.116.245373. Epub 2017 Apr 19.

44.

Estimating prevalence of functional iron deficiency anaemia in advanced cancer.

Neoh K, Stanworth S, Pasricha SR, Bennett MI.

Support Care Cancer. 2017 Apr;25(4):1209-1214. doi: 10.1007/s00520-016-3511-9. Epub 2016 Nov 29.

45.

Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.

Wray K, Allen A, Evans E, Fisher C, Premawardhena A, Perera L, Rodrigo R, Goonathilaka G, Ramees L, Webster C, Armitage AE, Prentice AM, Weatherall DJ, Drakesmith H, Pasricha SR.

Am J Hematol. 2017 Feb;92(2):196-203. doi: 10.1002/ajh.24617.

46.

Differentially regulated high-affinity iron assimilation systems support growth of the various cell types in the dimorphic pathogen Talaromyces marneffei.

Pasricha S, Schafferer L, Lindner H, Joanne Boyce K, Haas H, Andrianopoulos A.

Mol Microbiol. 2016 Nov;102(4):715-737. doi: 10.1111/mmi.13489. Epub 2016 Sep 23.

47.

Lifting the veil on fungal toxins.

Pasricha S, Pearson JS.

Cell Death Discov. 2016 May 30;2:16035. doi: 10.1038/cddiscovery.2016.35. eCollection 2016. No abstract available.

48.

Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia.

Armitage AE, Lim PJ, Frost JN, Pasricha SR, Soilleux EJ, Evans E, Morovat A, Santos A, Diaz R, Biggs D, Davies B, Gileadi U, Robbins PA, Lakhal-Littleton S, Drakesmith H.

J Innate Immun. 2016;8(5):517-28. doi: 10.1159/000447713. Epub 2016 Jul 16.

49.

A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.

Bah A, Wegmuller R, Cerami C, Kendall L, Pasricha SR, Moore SE, Prentice AM.

BMC Pregnancy Childbirth. 2016 Jul 13;16(1):157. doi: 10.1186/s12884-016-0934-8.

50.

Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia.

Pasricha S, Gupta A, Reed CC, Speck O, Woosley JT, Dellon ES.

Dig Dis Sci. 2016 Oct;61(10):2935-2941. doi: 10.1007/s10620-016-4230-2. Epub 2016 Jun 24.

Supplemental Content

Loading ...
Support Center